24.08.2020 15:04:20

XBiotech Shares Surge On FDA Emergency Use Authorization Of Convalescent Plasma

(RTTNews) - XBiotech Inc. (XBIT) announced the FDA issued an emergency use authorization for COVID-19 Convalescent Plasma as a COVID-19 treatment, opening the door for the company's antibody screening technology used to identify Convalescent Plasma. Under Collaboration, BioBridge Global will be using XBiotech's COVID-19 antibody test to identify the convalescent blood products.

XBiotech said the Agency's preliminary findings show that the use of convalescent plasma (or blood with natural anti-COVD-19 antibodies from patients that recovered from the infection) is safe and effective in treating COVID-19.

Shares of XBiotech were up 14% in pre-market trade on Monday.

Analysen zu XBiotech Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

XBiotech Inc 6,50 0,00% XBiotech Inc